| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash, cash equivalents and restricted cash-Consolidated Entity Excluding Variable Interest Entities VIE | 88,706 | |||
| Cash, cash equivalents and restricted cash-Variable Interest Entity Primary Beneficiary | 137,842 | |||
| Accounts receivable | 6,824 | |||
| Available-for-sale securities, at fair value | 692,818 | |||
| Prepaid expenses | 10,933 | |||
| Other current assets | 13,516 | |||
| Total current assets | 950,639 | |||
| Property, plant and equipment, net | 382,515 | |||
| Impairment-Licensing Agreements | 0 | |||
| Gross carrying amount | 24,857 | |||
| Accumulated amortization | 17,996 | |||
| Impairment | 0 | |||
| Intangible assets, net | 6,861 | |||
| Right-of-use assets | 43,891 | |||
| Other assets | 1,389 | |||
| Total assets | 1,385,295 | |||
| Accounts payable | 17,674 | |||
| Accrued expenses | 90,419 | |||
| Accrued payroll and benefits | 26,895 | |||
| Lease liabilities | 7,289 | |||
| Deferred revenue | 2,399 | |||
| Credit facility | 40,000 | |||
| Other liabilities | 10,811 | |||
| Total current liabilities | 195,487 | |||
| Lease liabilities, net of current portion | 104,112 | |||
| Liability related to the sale of future royalties | 367,397 | |||
| Credit facility, net of current portion | 214,883 | |||
| Total long-term liabilities | 686,392 | |||
| Common stock, 0.001 par value authorized 290,000 shares issued and outstanding 135,702 and 124,376 shares at september 30, 2025 and 2024, respectively | 231 | |||
| Additional paid-in capital | 2,139,725 | |||
| Accumulated other comprehensive income | 6,443 | |||
| Accumulated deficit | -1,627,154 | |||
| Treasury stock at cost 2,661 and 0 shares of common stock at september 30, 2025 and 2024, respectively | 53,193 | |||
| Total arrowhead pharmaceuticals, inc. stockholders' equity | 466,052 | |||
| Noncontrolling interest | 37,364 | |||
| Total noncontrolling interest and stockholders' equity | 503,416 | |||
| Total liabilities, noncontrolling interest and stockholders' equity | 1,385,295 | |||
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)